KLK3 and bone metastasis: Despite no significant differences in age, alkaline phosphatase, prostate-specific antigen or bone metastasis volume, DWIBS-PD group had a significantly higher proportion of patients with Eastern Cooperative Oncology Group performance status score of 2 before the treatment compared to DWIBS-non-PD group (P = 0.039).